Sickle Cell Disease in Social Security Disability Evaluations (2025)

Chapter: Appendix A: Public Meeting Agendas

Previous Chapter: 9 Overarching Conclusions
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.

Appendix A

Public Meeting Agendas

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Tuesday, November 19, 2024 (12:30–1:30 PM ET)
SESSION 1—OPEN

12:30–12:40

Welcome and Introductions

Paul Volberding, Committee Chair

Vince Nibali, Technical Expert, Office of Medical Policy, Social Security Administration (SSA)

12:40–1:00

Social Security Administration Overview

Vince Nibali, Technical Expert, Office of Medical Policy, Social Security Administration

1:00–1:30

Questions and Discussion

Jennifer Koop, Committee Vice Chair, Moderator Committee Members and SSA Staff

1:30

Adjourn Public Session

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, December 20, 2024 (1:00–4:00 PM ET)
WEBINAR 1: Hospitalization and Sickle Cell Disease (SCD)

1:00–1:10

Welcome Remarks and Introductions

Paul Volberding, Committee Chair

Jennifer Koop, Committee Vice Chair

1:10–1:30

Sponsor Remarks, Social Security Administration

Michael Goldstein, Director of the Office of Medical Policy, Social Security Administration

Andrea Bento, Technical Expert in the Office of Medical Policy, Social Security Administration

1:30–2:30

Session I: Living with SCD

Moderators

Coretta Jenerette, Committee Member

Marilyn Baffoe-Bonnie, Committee Member

Panelists

Tristan Lee, Professional model, actor, fashion designer, and patient advocate for SCD; SCD Warrior

Christelle Salomon, Health Policy and Education Analyst, University of California, San Francisco Benioff Children’s Hospitals; SCD Warrior

Sharee Turpin, Patient Navigator, University of Rochester Medicine; SCD Warrior

Nikia K. Vaughan, Executive Director, Maryland Sickle Cell Disease Association; SCD Caregiver

Teonna Woolford, CEO, Sickle Cell Reproductive Health Education Directive; SCD Warrior

Q & A with Panelists

2:30–2:45

Break

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
2:45–3:45

Session II: Hospitalization in SCD

Moderators

Jeffrey Glassberg, Committee Member

Ashley Jenkins, Committee Member

Panelists

Mary Hulihan, Health Scientist, Centers for Disease Control and Prevention

Caroline E. Freiermuth, Associate Professor of Clinical Emergency Medicine, University of Cincinnati College of Medicine

Ruchi Doshi, Hospital Medicine Specialist and Assistant Professor of Medicine, Duke University

Titilope Fasipe, Assistant Professor of Pediatrics and Co-Director, Sickle Cell Program, Baylor College of Medicine

Q & A with Panelists

3:45–3:55

Summary Statements

3:55–4:00

Closing Remarks

Paul Volberding, Committee Chair

Jennifer Koop, Committee Vice Chair

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, February 7, 2025 (1:00–4:00 PM ET)
WEBINAR 2: Pain Management and Sickle Cell Disease (SCD)

1:00–1:10

Welcome Remarks and Introductions

Paul Volberding, Committee Chair

Jennifer Koop, Committee Vice Chair

1:10–2:15

Session I: Living with and Managing Pain in SCD

Moderator

Shirley Johnson, Committee Member

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.

Panelists

Teanika Hoffman, Sickle Cell Coalition of Maryland

Carolyn Rowley, Cayenne Wellness Center

Q & A with Panelists

2:15–2:30

Break

2:30–3:45

Session II: Pain Management in SCD

Moderators

Trish Kavanagh, Committee Member

Martha Kenney, Committee Member

Mechanisms of Pain Presentation

Daniel Sop, Virginia Commonwealth University

Panelists

Amanda Brandow, Medical College of Wisconsin

Pat Carroll, Johns Hopkins University

Wally Smith, Virginia Commonwealth University

Lara Zador, Henry Ford Health

Q & A with Panelists

3:45–3:55

Summary Statements

3:55–4:00

Closing Remarks

Paul Volberding, Committee Chair

Jennifer Koop, Committee Vice Chair

COMMITTEE ON SICKLE CELL DISEASE IN SOCIAL SECURITY DISABILITY EVALUATIONS

Virtual Public Session

Friday, February 21, 2025 (10:00 AM–1:00 PM ET)
WEBINAR 3: Functional Outcomes of Sickle Cell Disease (SCD)—The Whole-Person Experience

10:00–10:05

Welcome Remarks and Introductions

Jennifer Koop, Committee Vice Chair

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
10:05–11:15

Session I: Functional Outcomes in SCD

Moderator

Cece Calhoun, Committee Member

Panelists

Payal Desai, Atrium Health

Kelly Harris, Washington University in St. Louis

Eboni Lance, Kennedy Krieger Institute/Johns Hopkins University

Lakeya McGill, University of Pittsburgh

Jean Leclerc Raphael, Texas Children’s/Baylor College of Medicine

Q & A with Panelists

11:15–11:30

Break

11:30–12:45

Session II: SCD and Daily Life: Lived Experience

Moderator

Jerlym Porter, Committee Member

Panelists

Omini Ewah, OBIA Naturals; SCD Warrior

Golda Houndoh, PCORI; SCD Warrior

Vesha Jamison, American Red Cross; Caretaker

Q & A with Panelists

12:45–12:55

Summary Statements

12:55–1:00

Closing Remarks

Jennifer Koop, Committee Vice Chair

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.

This page intentionally left blank.

Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 235
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 236
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 237
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 238
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 239
Suggested Citation: "Appendix A: Public Meeting Agendas." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 240
Next Chapter: Appendix B: Draft Medical Report Forms for Children and Adults with Sickle Cell Disease
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.